WO2003106447A1 - Process for the preparation of dioxane acetic acid esters - Google Patents
Process for the preparation of dioxane acetic acid esters Download PDFInfo
- Publication number
- WO2003106447A1 WO2003106447A1 PCT/NL2003/000435 NL0300435W WO03106447A1 WO 2003106447 A1 WO2003106447 A1 WO 2003106447A1 NL 0300435 W NL0300435 W NL 0300435W WO 03106447 A1 WO03106447 A1 WO 03106447A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- acid chloride
- group
- process according
- ester
- Prior art date
Links
- 0 *C[C@@]1OC(*)(*)O[C@@](CC(O)=O)C1 Chemical compound *C[C@@]1OC(*)(*)O[C@@](CC(O)=O)C1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Definitions
- R 2 represents an ester residue, preferably an alkyl group, for instance an alkyl group with 1-6 C-atoms or an aryl group, for instance an aryl group with 6-12 C-atoms, in particular a methyl, ethyl, propyl, isobutyl or t.butyl group.
- An important group of esters that can be prepared with the process according to the invention are t.butyl esters.
- the conversion of the acid chloride into the ester with formula (1) is carried out in the presence of an alcohol with formula R 2 OH.
- the amount of alcohol with formula R 2 OH is not very critical and preferably is between 1 and 15 equivalent calculated with respect to the amount of salt with formula (2), more preferably between 2 and 13, most preferably between 3 and 6. Surprisingly it has been found that even t.-butyl esters can be prepared with high yield using a relatively low amount of t.-butyl alcohol.
- the compound with formula 1 wherein R 1 represents an acyloxy group can be converted in the corresponding compound wherein R 1 represents a hydroxy group, for instance by subjecting it to solvolysis in the presence of a base.
- Suitable bases are, for instance, alkali (earth) metal hydroxides or carbonates or organic bases, for instance alkali (earth) metal carboxylic acids, for instance acetates, ammonia, pyridines, amines, for instance triethylamine and the like.
- the ethyl, isopropyl and n-hexyl esters are prepared wherein instead of 4 eq. butanol, now 4 eq. ethanol, 4 eq. isopropanol and 4 eq. n-hexanol, respectively is used.
- the yield of the desired ethyl, isopropyl and n-hexyl ester was 89 mol%, 88 mol% and 84 mol% respectively, calculated with respect to the sodium salt starting material.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003277230A AU2003277230B2 (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters |
SI200330658T SI1515962T1 (en) | 2002-06-17 | 2003-06-12 | Process for the preaparation of dioxane acetic acid esters |
MXPA04012651A MXPA04012651A (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters. |
DK03741639T DK1515962T3 (en) | 2002-06-17 | 2003-06-12 | Process for preparing dioxane acetic acid esters |
CN038140373A CN1662520B (en) | 2002-06-17 | 2003-06-12 | Process for the preaparation of dioxane acetic acid esters |
BR0311884-3A BR0311884A (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of an ester |
JP2004513279A JP4632784B2 (en) | 2002-06-17 | 2003-06-12 | Process for producing dioxane acetates |
US10/518,164 US7442811B2 (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters |
CA2490205A CA2490205C (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters |
DE60310559T DE60310559T2 (en) | 2002-06-17 | 2003-06-12 | PROCESS FOR THE PREPARATION OF DIOXANEIC ACID ESTERS |
EP03741639A EP1515962B1 (en) | 2002-06-17 | 2003-06-12 | Process for the preaparation of dioxane acetic acid esters |
KR1020047020617A KR101008920B1 (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters |
NZ537260A NZ537260A (en) | 2002-06-17 | 2003-06-12 | Process that results in sterically hindered esters that are difficult to obtain in esterifications like t-butyl esters are obtained in high yield in an easily reproducible process |
UAA200500156A UA79970C2 (en) | 2002-06-17 | 2003-12-06 | Process for the preparation of ester |
IL16576704A IL165767A0 (en) | 2002-06-17 | 2004-12-14 | Process for the preparation of dioxane acetic acidesters |
EGNA2004000143 EG24561A (en) | 2002-06-17 | 2004-12-15 | Process for the preparation of dioxane acetic acidesters |
NO20045491A NO328946B1 (en) | 2002-06-17 | 2004-12-16 | Process for the preparation of dioxane acetic acid esters |
IS7617A IS2477B (en) | 2002-06-17 | 2004-12-28 | Process for producing dioxane acetic acid esters |
HK05105964A HK1073303A1 (en) | 2002-06-17 | 2005-07-13 | Process for the preparation of dioxane acetic acidesters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02100715.8 | 2002-06-17 | ||
EP02100715A EP1375493A1 (en) | 2002-06-17 | 2002-06-17 | Process for the preparation of an dioxane acetic acid ester |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003106447A1 true WO2003106447A1 (en) | 2003-12-24 |
Family
ID=29716908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2003/000435 WO2003106447A1 (en) | 2002-06-17 | 2003-06-12 | Process for the preparation of dioxane acetic acid esters |
Country Status (27)
Country | Link |
---|---|
US (1) | US7442811B2 (en) |
EP (2) | EP1375493A1 (en) |
JP (1) | JP4632784B2 (en) |
KR (1) | KR101008920B1 (en) |
CN (2) | CN101812045B (en) |
AT (1) | ATE348825T1 (en) |
AU (1) | AU2003277230B2 (en) |
BR (1) | BR0311884A (en) |
CA (1) | CA2490205C (en) |
CY (1) | CY1107344T1 (en) |
DE (1) | DE60310559T2 (en) |
DK (1) | DK1515962T3 (en) |
EG (1) | EG24561A (en) |
ES (1) | ES2278174T3 (en) |
HK (1) | HK1073303A1 (en) |
IL (1) | IL165767A0 (en) |
IS (1) | IS2477B (en) |
MX (1) | MXPA04012651A (en) |
NO (1) | NO328946B1 (en) |
NZ (1) | NZ537260A (en) |
PL (1) | PL207130B1 (en) |
PT (1) | PT1515962E (en) |
RU (1) | RU2315761C2 (en) |
SI (1) | SI1515962T1 (en) |
UA (1) | UA79970C2 (en) |
WO (1) | WO2003106447A1 (en) |
ZA (1) | ZA200409986B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157255B2 (en) | 2000-05-09 | 2007-01-02 | Astrazeneca Uk Limited | Process for the preparation of dihydroxy esters and derivatives thereof |
US7304156B2 (en) | 2001-07-13 | 2007-12-04 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
US7511140B2 (en) | 2002-08-13 | 2009-03-31 | Astrazeneca Ab | Process for preparing the calcium salt of rosuvastatin |
US7524955B2 (en) | 2002-12-16 | 2009-04-28 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
US7642363B2 (en) | 2000-07-19 | 2010-01-05 | Astrazeneca Uk Ltd. | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-YL) acetic acid derivatives |
US7718812B2 (en) | 2001-12-27 | 2010-05-18 | Astrazeneca Uk Limited | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivates |
US8034932B2 (en) | 2004-12-24 | 2011-10-11 | Astrazeneca Uk Limited | Chemical process |
US8063213B2 (en) | 2003-06-05 | 2011-11-22 | Astrazeneca Uk Limited | Production of rosuvastatin calcium salt |
WO2012017242A1 (en) * | 2010-08-05 | 2012-02-09 | Bakhu Pharma Limited | Process |
US8436167B2 (en) | 2003-09-10 | 2013-05-07 | Astrazeneca Uk Limited | Chemical compounds |
US9371291B2 (en) | 2003-10-24 | 2016-06-21 | Astrazeneca Uk Limited | Process for the manufacture of the calcium salt of rosuvastatin (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S)-3,5-Dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0514078D0 (en) * | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
CN105198856B (en) * | 2014-06-27 | 2017-10-13 | 上海弈柯莱生物医药科技有限公司 | The preparation method of one kind 2 (6 substitution 1,3 dioxane 4 base) acetogenin |
RU2596623C1 (en) * | 2015-07-20 | 2016-09-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уфимский государственный нефтяной технический университет" | Method for producing 1,4-dioxancarboxylate |
CN111675689B (en) * | 2020-06-16 | 2021-08-24 | 浙江工业大学 | Chemical synthesis method of rosuvastatin intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB885516A (en) * | 1958-01-16 | 1961-12-28 | Arthur Henry Clarkson | Higher fatty acid esters of dextran |
WO2000068221A1 (en) * | 1999-05-06 | 2000-11-16 | EGIS Gyógyszergyár Rt. | Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof |
WO2002006266A1 (en) * | 2000-07-19 | 2002-01-24 | Dsm N.V. | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3325466A (en) | 1961-01-11 | 1967-06-13 | American Cyanamid Co | Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides |
GB9005966D0 (en) | 1990-03-16 | 1990-05-09 | May & Baker Ltd | New compositions of matter |
JP3097143B2 (en) | 1991-02-21 | 2000-10-10 | チッソ株式会社 | Method for producing optically active compound for synthesis of physiologically active substance and optically active intermediate compound |
EP0604483A1 (en) | 1991-09-20 | 1994-07-06 | Zeneca Limited | Process for the preparation of enantiomerically pure 4-hydroxytetrahydro-2-pyranone derivatives |
WO1993008823A1 (en) | 1991-11-06 | 1993-05-13 | Tanabe Seiyaku Co., Ltd. | Guanidinyl and related cell adhesion modulation compounds |
US5278313A (en) | 1992-03-27 | 1994-01-11 | E. R. Squibb & Sons, Inc. | Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors |
US5795749A (en) | 1995-04-05 | 1998-08-18 | The Scripps Research Institution | Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives |
GB9523924D0 (en) | 1995-11-23 | 1996-01-24 | Zeneca Ltd | Production of optically active 2-substituted tetrahydropyran-4-ones |
FR2741620B1 (en) | 1995-11-28 | 1997-12-26 | Oreal | PROCESS FOR THE PREPARATION OF COMPOUNDS WITH A BETA-HYDROXY -DELTA-LACTONE GROUP ANALOGS OF (+) COMPACTIN AND (+) MEVINOLINE |
US6278001B1 (en) | 1995-11-28 | 2001-08-21 | L'oréal | Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping |
EP1077212B1 (en) | 1998-04-30 | 2003-08-20 | Kaneka Corporation | Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives |
US6472544B1 (en) | 1998-08-05 | 2002-10-29 | Kaneka Corporation | Process for the preparation of optically active 2-[6-hydroxymethyl)-1,3-dioxan-4yl]acetic acid derivatives |
HUP0103021A3 (en) | 1998-12-10 | 2002-04-29 | Kaneka Corp | Process for producing simvastatin derivatives |
GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
ES2219345T3 (en) | 1999-06-04 | 2004-12-01 | Kaneka Corporation | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF THE 5-HYDROXY-3-OXOPENTANOIC ACID. |
AU2000254249A1 (en) | 2000-03-28 | 2001-10-08 | Biocon India Limited | Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1- |
GB0011120D0 (en) | 2000-05-09 | 2000-06-28 | Avecia Ltd | Process |
EP1417180B1 (en) | 2001-07-13 | 2006-12-27 | AstraZeneca UK Limited | Preparation of aminopyrimidine compounds |
EP1323717A1 (en) | 2001-12-27 | 2003-07-02 | Dsm N.V. | Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives |
GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
EP2088142A3 (en) | 2002-12-16 | 2010-04-21 | AstraZeneca UK Limited | Dihydropyrimidines, process for their preparation and use thereof. |
GB0312896D0 (en) | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
WO2004113314A1 (en) | 2003-06-23 | 2004-12-29 | Biocon Limited | Novel boronate esters |
UY28501A1 (en) | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | CHEMICAL COMPOUNDS |
GB0321827D0 (en) | 2003-09-18 | 2003-10-15 | Astrazeneca Uk Ltd | Chemical compounds |
GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
TWI276043B (en) | 2004-09-09 | 2007-03-11 | Seiko Epson Corp | Display apparatus |
GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
-
2002
- 2002-06-17 EP EP02100715A patent/EP1375493A1/en not_active Withdrawn
-
2003
- 2003-06-12 DE DE60310559T patent/DE60310559T2/en not_active Expired - Lifetime
- 2003-06-12 WO PCT/NL2003/000435 patent/WO2003106447A1/en active IP Right Grant
- 2003-06-12 CN CN2010101725560A patent/CN101812045B/en not_active Expired - Lifetime
- 2003-06-12 MX MXPA04012651A patent/MXPA04012651A/en active IP Right Grant
- 2003-06-12 US US10/518,164 patent/US7442811B2/en not_active Expired - Fee Related
- 2003-06-12 PT PT03741639T patent/PT1515962E/en unknown
- 2003-06-12 NZ NZ537260A patent/NZ537260A/en not_active IP Right Cessation
- 2003-06-12 BR BR0311884-3A patent/BR0311884A/en not_active IP Right Cessation
- 2003-06-12 EP EP03741639A patent/EP1515962B1/en not_active Expired - Lifetime
- 2003-06-12 CN CN038140373A patent/CN1662520B/en not_active Expired - Lifetime
- 2003-06-12 AU AU2003277230A patent/AU2003277230B2/en not_active Ceased
- 2003-06-12 JP JP2004513279A patent/JP4632784B2/en not_active Expired - Fee Related
- 2003-06-12 PL PL375077A patent/PL207130B1/en not_active IP Right Cessation
- 2003-06-12 AT AT03741639T patent/ATE348825T1/en active
- 2003-06-12 ES ES03741639T patent/ES2278174T3/en not_active Expired - Lifetime
- 2003-06-12 CA CA2490205A patent/CA2490205C/en not_active Expired - Fee Related
- 2003-06-12 SI SI200330658T patent/SI1515962T1/en unknown
- 2003-06-12 DK DK03741639T patent/DK1515962T3/en active
- 2003-06-12 KR KR1020047020617A patent/KR101008920B1/en not_active IP Right Cessation
- 2003-06-12 RU RU2004139042/04A patent/RU2315761C2/en not_active IP Right Cessation
- 2003-12-06 UA UAA200500156A patent/UA79970C2/en unknown
-
2004
- 2004-12-09 ZA ZA200409986A patent/ZA200409986B/en unknown
- 2004-12-14 IL IL16576704A patent/IL165767A0/en not_active IP Right Cessation
- 2004-12-15 EG EGNA2004000143 patent/EG24561A/en active
- 2004-12-16 NO NO20045491A patent/NO328946B1/en not_active IP Right Cessation
- 2004-12-28 IS IS7617A patent/IS2477B/en unknown
-
2005
- 2005-07-13 HK HK05105964A patent/HK1073303A1/en not_active IP Right Cessation
-
2007
- 2007-02-16 CY CY20071100215T patent/CY1107344T1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB885516A (en) * | 1958-01-16 | 1961-12-28 | Arthur Henry Clarkson | Higher fatty acid esters of dextran |
WO2000068221A1 (en) * | 1999-05-06 | 2000-11-16 | EGIS Gyógyszergyár Rt. | Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof |
WO2002006266A1 (en) * | 2000-07-19 | 2002-01-24 | Dsm N.V. | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives |
Non-Patent Citations (2)
Title |
---|
MARCH J: "ALIPHATIC NUCLEOPHILIC SUBSTITUTION", ADVANCED ORGANIC CHEMISTRY. REACTIONS, MECHANISMS, AND STRUCTURE, NEW YORK, JOHN WILEY & SONS, US, 1992, pages 392, XP002217003, ISBN: 0-471-60180-2 * |
MURPHY C F, KOEHLER R. E.: "CHEMISTRY OF CEPHALOSPORIN ANTIBIOTICS. XVIII.", J. ORG. CHEM., vol. 35, no. 7, 1970, pages 2429 - 2430, XP002252465 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157255B2 (en) | 2000-05-09 | 2007-01-02 | Astrazeneca Uk Limited | Process for the preparation of dihydroxy esters and derivatives thereof |
US7888083B2 (en) | 2000-05-09 | 2011-02-15 | Astrazeneca Uk Limited | Process for the preparation of dihydroxy esters and derivatives thereof |
US7416865B2 (en) | 2000-05-09 | 2008-08-26 | Astrazeneca Uk Limited | Process for the preparation of dihydroxy esters and derivatives thereof |
US7732171B2 (en) | 2000-05-09 | 2010-06-08 | Astrazeneca Uk Limited | Process for the preparation of dihydroxy esters and derivatives thereof |
US7642363B2 (en) | 2000-07-19 | 2010-01-05 | Astrazeneca Uk Ltd. | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-YL) acetic acid derivatives |
US7989643B2 (en) | 2000-07-19 | 2011-08-02 | Astrazeneca Uk Ltd. | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives |
US7816528B2 (en) | 2001-07-13 | 2010-10-19 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
US8222412B2 (en) | 2001-07-13 | 2012-07-17 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
US8614320B2 (en) | 2001-07-13 | 2013-12-24 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
US7304156B2 (en) | 2001-07-13 | 2007-12-04 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
US7718812B2 (en) | 2001-12-27 | 2010-05-18 | Astrazeneca Uk Limited | Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivates |
US7842807B2 (en) | 2002-08-13 | 2010-11-30 | Astrazeneca Uk Limited | Process for preparing the calcium salt of rosuvastatin |
US7511140B2 (en) | 2002-08-13 | 2009-03-31 | Astrazeneca Ab | Process for preparing the calcium salt of rosuvastatin |
US8273878B2 (en) | 2002-12-16 | 2012-09-25 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
US7524955B2 (en) | 2002-12-16 | 2009-04-28 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
US8063213B2 (en) | 2003-06-05 | 2011-11-22 | Astrazeneca Uk Limited | Production of rosuvastatin calcium salt |
US8436167B2 (en) | 2003-09-10 | 2013-05-07 | Astrazeneca Uk Limited | Chemical compounds |
US9371291B2 (en) | 2003-10-24 | 2016-06-21 | Astrazeneca Uk Limited | Process for the manufacture of the calcium salt of rosuvastatin (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S)-3,5-Dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
US8034932B2 (en) | 2004-12-24 | 2011-10-11 | Astrazeneca Uk Limited | Chemical process |
WO2012017242A1 (en) * | 2010-08-05 | 2012-02-09 | Bakhu Pharma Limited | Process |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1515962B1 (en) | Process for the preaparation of dioxane acetic acid esters | |
JPH0258272B2 (en) | ||
JPH0615514B2 (en) | Method for N, ω trifluoroacetylation of saturated aliphatic α, ω-diaminomonocarboxylic acid | |
JPH09110832A (en) | Production of 4-acylamino-2,2,6,6-tetramethylpiperazine | |
US5652371A (en) | 3-imino-3-alkoxy-propionic acid lactates and their tautomeric acrylic acid lactates | |
US6291710B1 (en) | Process for preparing sulfonyl halides | |
CN112272665A (en) | Process for preparing sitagliptin | |
JPH09255668A (en) | Production of bisoxazolines | |
JP4799085B2 (en) | Process for producing optically active N-substituted aminoacyl cyclic urea derivative | |
JP2002155058A (en) | Method for producing 1-substituted hydratoin compound | |
JP2959811B2 (en) | Manufacturing method of acid chloride | |
RU2014325C1 (en) | Method of synthesis of s,s-di(lower alkyl)-ester of 4-(lower alkyl)-2,6-bis- (trifluoromethyl)-2,6-dihydroxy-3,5-piperidine dicarbothioacid | |
JP3013022B2 (en) | Method for producing alkyl 3-phthalidylideneacetate | |
JP2821630B2 (en) | Method for producing Z- (alkoxycarbonyl) ethyl phosphinate | |
JPH1084989A (en) | Production of optically active alpha-ionone | |
JPH09124601A (en) | Production of piperidones | |
JP2001247549A (en) | Method of producing 1-position substituted hydantoins | |
US20030181729A1 (en) | Production process for 5-alkyl-oxazolidin-2,4-dione | |
JPH10273486A (en) | Production of 4-(2-alkenyl)-2,5-oxazolidinediones | |
JPH08301854A (en) | Production of pyrazolones | |
JP2006502201A (en) | Improved synthon synthesis | |
JPH08208530A (en) | Removal of phthaloyl group from phthalimide | |
JPH10175926A (en) | Optically active alcohol and carboxylic acid ester thereof | |
JPH0737429B2 (en) | Method for producing monoarylmalonic acid amides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003741639 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003277230 Country of ref document: AU Ref document number: 200409986 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/012651 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2490205 Country of ref document: CA Ref document number: 537260 Country of ref document: NZ Ref document number: 3996/DELNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 375077 Country of ref document: PL Ref document number: 2004513279 Country of ref document: JP Ref document number: 1020047020617 Country of ref document: KR Ref document number: 20038140373 Country of ref document: CN Ref document number: 1-2004-502060 Country of ref document: PH |
|
ENP | Entry into the national phase |
Ref document number: 2004139042 Country of ref document: RU Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2003741639 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047020617 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2006122407 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10518164 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10518164 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003741639 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003277230 Country of ref document: AU |